TABLE 3.

Comparisons of laboratory examination results and PDGF‐BB levels between control group and CHD group

	Control group (n = 86)	CHD group (n = 247)	t/Z	p
Glu (mmol/L)	5.50 ± 1.09	5.69 ± 1.47	−1.330	0.185
TC (mmol/L)	4.62 ± 1.13	4.59 ± 1.17	0.219	0.827
TG (mmol/L)	1.58 ± 0.85	1.86 ± 1.39	−1.761	0.079
HDLc (mmol/L)	1.16 ± 0.33	1.05 ± 0.41	2.451	0.015*
LDLc (mmol/L)	2.88 ± 0.91	2.88 ± 1.01	−0.010	0.992
WBC (×109/L)	6.39 ± 1.50	6.67 ± 1.53	−1.478	0.140
Plt (×109/L)	234.25 ± 54.07	228.60 ± 55.82	0.823	0.411
hsCRP (mg/L)	0.83 (0.44, 2.32)	1.41 (0.63, 3.28)	2.573	0.010**
PDGF‐BB (pg/ml)	224.10 ± 111.83	258.37 ± 132.40	−2.168	0.031*

Note: The measurement data (Glu, TC, TG, HDLc, LDLc, WBC, Plt, PDGF‐BB) were shown by mean ± SD, and the comparison between control group and CHD group was analyzed by t test. The data of hsCRP level that did not match normal distribution were expressed as median and quartile M (P25, P75), the comparison between groups was analyzed by nonparametric Mann–Whitney U test. Other measurement data between control group and CHD group were analyzed by t test (*p < 0.05, **p < 0.01).

Abbreviations: CHD, coronary heart disease; Glu, Glucose; HDLc, high‐density lipoprotein cholesterol; hsCRP, high sensitivity C‐reactive protein; LDLc, low‐density lipoprotein cholesterol; PDGF‐BB, platelet‐derived growth factor‐BB; Plt, blood platelet; TC, total cholesterol; TG, triglyceride; WBC, white blood cells.